Response to: "Contraceptive safety in liver disease: The cost of overstating risk". Phaloprakarn C, Tangjitgamol S, Sethasine S, Suthasmalee S, et al. Contraception 2025;152:111048.

Read + Share

Amedeo Smart

Independent Medical Education

Phaloprakarn C, Tangjitgamol S, Sethasine S, Suthasmalee S, et al. Response to: "Contraceptive safety in liver disease: The cost of overstating risk". Contraception 2025;152:111048.
PMID: 41173584